Medlive Technology Co., Ltd. (HKG:2192)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Healthcare Software	642.16M	558.46M	412.00M	314.05M	284.44M
Healthcare Software Growth	14.99%	35.55%	31.19%	10.41%	33.21%
Total	642.16M	558.46M	412.00M	314.05M	284.44M
Total Growth	14.99%	35.55%	31.19%	10.41%	33.21%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Overseas	13.22M	10.83M	9.87M	17.17M	10.79M
Overseas Growth	22.00%	9.71%	-42.49%	59.18%	192.04%
Mainland China	628.94M	547.62M	402.13M	296.89M	273.66M
Mainland China Growth	14.85%	36.18%	35.45%	8.49%	30.41%
Total	642.16M	558.46M	412.00M	314.05M	284.44M
Total Growth	14.99%	35.55%	31.19%	10.41%	33.21%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jul 10, 2026

Data Sources Report a data error